Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.
about
The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantationHow do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMTDonor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsUnrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the AAllogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning.Regulatory T Cell Immunotherapy in Immune-Mediated DiseasesAllogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity.Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT.Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell TransplantationValidation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Clinical trials of CAR-T cells in ChinaPlatelet transfusion refractoriness after T-cell-replete haploidentical transplantation is associated with inferior clinical outcomes.
P2860
Q26748595-B052CD4D-5B2D-4F86-87A2-CC9D7EEFD844Q26748867-3661247B-7679-4DD5-AFDE-E7CDCE97A5A1Q33755190-D22C7A2B-F52E-4470-862E-1BB1DB0095EEQ33820379-0779ACDA-1294-4CAE-B391-106ED0F738D5Q35834570-9DA07275-FE92-4B25-A99F-C66B1EB53187Q36125603-608FB3D8-FE4C-4886-A366-FE2C42966A8DQ36426327-AD9FC405-3049-490A-9BB9-27CF4D098D6CQ36462109-5BD5642A-AF42-46CC-B71F-D71D2F3F2DAFQ36577708-0812CED5-770C-45CA-8630-38245674BFF0Q37064425-0E43A17A-36C4-4CBD-95AF-1AE7AC2373DFQ37362718-71A17EFB-DD49-45ED-832D-0F64F2F8E5ABQ37618811-056C94AF-16EE-43E4-9EEA-B5328D5B56CDQ38616695-1BD400C0-37E1-450A-8280-ACFEF9D1F395Q38698528-01F35E4F-859D-4F92-A5EB-0C320099A6BFQ38816505-549C1892-98DA-4988-9F64-FF5C92014B02Q42654456-BB5AFDF2-1FF1-422A-AF88-CC2606B90A64Q50072576-7A202118-651D-4E5B-B56E-32D4EBD923B5
P2860
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Non-myeloablative allogeneic h ...... Belgian Hematological Society.
@ast
Non-myeloablative allogeneic h ...... Belgian Hematological Society.
@en
type
label
Non-myeloablative allogeneic h ...... Belgian Hematological Society.
@ast
Non-myeloablative allogeneic h ...... Belgian Hematological Society.
@en
prefLabel
Non-myeloablative allogeneic h ...... Belgian Hematological Society.
@ast
Non-myeloablative allogeneic h ...... Belgian Hematological Society.
@en
P2093
P2860
P50
P1476
Non-myeloablative allogeneic h ...... Belgian Hematological Society
@en
P2093
Aurélie Ory
Carlos Graux
Evelyne Willems
Frédéric Baron
Johan Maertens
Koen Theunissen
Laurence Seidel
Michel Van Gelder
Philippe Lewalle
Tessa Kerre
P2860
P2888
P356
10.1186/S13045-014-0098-9
P577
2015-02-06T00:00:00Z
P5875
P6179
1034406647